APO Research
Talk to an analyst

APO RESEARCH · REPORT

Liver Diseases Therapeutics Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Liver Diseases Therapeutics Drugs Industry Growth and Trends Forecast to 2032

20 December 2025115 pages

Choose your research edition.

Industry ResearchLiver Diseases Therapeutics Drugs Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Liver Diseases Therapeutics Drugs Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Liver Diseases Therapeutics Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Liver Diseases Therapeutics Drugs Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Liver Diseases Therapeutics Drugs Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Liver Diseases Therapeutics Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Liver Diseases Therapeutics Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Liver Diseases Therapeutics Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Liver Diseases Therapeutics Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Liver Diseases Therapeutics Drugs include Achillion Pharmaceuticals, Angion Biomedica, F. Hoffmann-La Roche, Gilead Sciences, LG Life Sciences, Phenex Pharmaceuticals, ProMetic Life Sciences, Raptor Pharmaceuticals and Verva Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Liver Diseases Therapeutics Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Liver Diseases Therapeutics Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Liver Diseases Therapeutics Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Liver Diseases Therapeutics Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Liver Diseases Therapeutics Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Liver Diseases Therapeutics Drugs Market by Company

Achillion Pharmaceuticals

Angion Biomedica

F. Hoffmann-La Roche

Gilead Sciences

LG Life Sciences

Phenex Pharmaceuticals

ProMetic Life Sciences

Raptor Pharmaceuticals

Verva Pharmaceuticals

AbbVie

Bayer

GlaxoSmithKline

Merck

Johnson & Johnson

Shenzhen Kangtai Biological Products

Liver Diseases Therapeutics Drugs Segment by Type

Oral Liver Diseases Therapeutics Drugs

Injection Liver Diseases Therapeutics Drugs

Liver Diseases Therapeutics Drugs Segment by Application

Hospitals

Clinics

Other

Liver Diseases Therapeutics Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liver Diseases Therapeutics Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Liver Diseases Therapeutics Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liver Diseases Therapeutics Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Liver Diseases Therapeutics Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Liver Diseases Therapeutics Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oral Liver Diseases Therapeutics Drugs Table 2. Major Company of Injection Liver Diseases Therapeutics Drugs Table 3. Global Liver Diseases Therapeutics Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Liver Diseases Therapeutics Drugs Sales by Type (2021-2026) & (K Units) Table 5. Global Liver Diseases Therapeutics Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Liver Diseases Therapeutics Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Liver Diseases Therapeutics Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global Liver Diseases Therapeutics Drugs Price by Type (2021-2026) & (US$/Unit) Table 9. Global Liver Diseases Therapeutics Drugs Sales by Type (2027-2032) & (K Units) Table 10. Global Liver Diseases Therapeutics Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Liver Diseases Therapeutics Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Liver Diseases Therapeutics Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global Liver Diseases Therapeutics Drugs Price by Type (2027-2032) & (US$/Unit) Table 14. North America Liver Diseases Therapeutics Drugs Sales by Type (2021-2026) & (K Units) Table 15. North America Liver Diseases Therapeutics Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Liver Diseases Therapeutics Drugs Sales by Type (2021-2026) & (K Units) Table 17. Europe Liver Diseases Therapeutics Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Liver Diseases Therapeutics Drugs Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Liver Diseases Therapeutics Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Liver Diseases Therapeutics Drugs Sales by Type (2021-2026) & (K Units) Table 21. Latin America Liver Diseases Therapeutics Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Liver Diseases Therapeutics Drugs Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Liver Diseases Therapeutics Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Liver Diseases Therapeutics Drugs Industry Trends Table 25. Liver Diseases Therapeutics Drugs Industry Drivers Table 26. Liver Diseases Therapeutics Drugs Industry Opportunities and Challenges Table 27. Liver Diseases Therapeutics Drugs Industry Restraints Table 28. Global Liver Diseases Therapeutics Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Liver Diseases Therapeutics Drugs Revenue Market Share by Company (2021-2026) Table 30. Global Liver Diseases Therapeutics Drugs Sales by Company (2021-2026) & (K Units) Table 31. Global Liver Diseases Therapeutics Drugs Sales Share by Company (2021-2026) Table 32. Global Liver Diseases Therapeutics Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Liver Diseases Therapeutics Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Liver Diseases Therapeutics Drugs Major Company Production Sites and Headquarters Table 35. Global Liver Diseases Therapeutics Drugs Company, Product Type & Application Table 36. Global Liver Diseases Therapeutics Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Liver Diseases Therapeutics Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Liver Diseases Therapeutics Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Liver Diseases Therapeutics Drugs Sales by Region (2021-2026) & (K Units) Table 41. Global Liver Diseases Therapeutics Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Liver Diseases Therapeutics Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Liver Diseases Therapeutics Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global Liver Diseases Therapeutics Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Liver Diseases Therapeutics Drugs Sales by Region (2027-2032) & (K Units) Table 46. Global Liver Diseases Therapeutics Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Liver Diseases Therapeutics Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Liver Diseases Therapeutics Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global Liver Diseases Therapeutics Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Liver Diseases Therapeutics Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Liver Diseases Therapeutics Drugs Sales by Application (2021-2026) & (K Units) Table 52. Global Liver Diseases Therapeutics Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Liver Diseases Therapeutics Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Liver Diseases Therapeutics Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global Liver Diseases Therapeutics Drugs Price by Application (2021-2026) & (US$/Unit) Table 56. Global Liver Diseases Therapeutics Drugs Sales by Application (2027-2032) & (K Units) Table 57. Global Liver Diseases Therapeutics Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Liver Diseases Therapeutics Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Liver Diseases Therapeutics Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global Liver Diseases Therapeutics Drugs Price by Application (2027-2032) & (US$/Unit) Table 61. North America Liver Diseases Therapeutics Drugs Sales by Application (2021-2026) & (K Units) Table 62. North America Liver Diseases Therapeutics Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Liver Diseases Therapeutics Drugs Sales by Application (2021-2026) & (K Units) Table 64. Europe Liver Diseases Therapeutics Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Liver Diseases Therapeutics Drugs Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Liver Diseases Therapeutics Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Liver Diseases Therapeutics Drugs Sales by Application (2021-2026) & (K Units) Table 68. Latin America Liver Diseases Therapeutics Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Liver Diseases Therapeutics Drugs Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Liver Diseases Therapeutics Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Achillion Pharmaceuticals Company Information Table 72. Achillion Pharmaceuticals Business Overview Table 73. Achillion Pharmaceuticals Liver Diseases Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Achillion Pharmaceuticals Liver Diseases Therapeutics Drugs Product Portfolio Table 75. Achillion Pharmaceuticals Recent Development Table 76. Angion Biomedica Company Information Table 77. Angion Biomedica Business Overview Table 78. Angion Biomedica Liver Diseases Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Angion Biomedica Liver Diseases Therapeutics Drugs Product Portfolio Table 80. Angion Biomedica Recent Development Table 81. F. Hoffmann-La Roche Company Information Table 82. F. Hoffmann-La Roche Business Overview Table 83. F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Product Portfolio Table 85. F. Hoffmann-La Roche Recent Development Table 86. Gilead Sciences Company Information Table 87. Gilead Sciences Business Overview Table 88. Gilead Sciences Liver Diseases Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Gilead Sciences Liver Diseases Therapeutics Drugs Product Portfolio Table 90. Gilead Sciences Recent Development Table 91. LG Life Sciences Company Information Table 92. LG Life Sciences Business Overview Table 93. LG Life Sciences Liver Diseases Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. LG Life Sciences Liver Diseases Therapeutics Drugs Product Portfolio Table 95. LG Life Sciences Recent Development Table 96. Phenex Pharmaceuticals Company Information Table 97. Phenex Pharmaceuticals Business Overview Table 98. Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Product Portfolio Table 100. Phenex Pharmaceuticals Recent Development Table 101. ProMetic Life Sciences Company Information Table 102. ProMetic Life Sciences Business Overview Table 103. ProMetic Life Sciences Liver Diseases Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. ProMetic Life Sciences Liver Diseases Therapeutics Drugs Product Portfolio Table 105. ProMetic Life Sciences Recent Development Table 106. Raptor Pharmaceuticals Company Information Table 107. Raptor Pharmaceuticals Business Overview Table 108. Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Product Portfolio Table 110. Raptor Pharmaceuticals Recent Development Table 111. Verva Pharmaceuticals Company Information Table 112. Verva Pharmaceuticals Business Overview Table 113. Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Product Portfolio Table 115. Verva Pharmaceuticals Recent Development Table 116. AbbVie Company Information Table 117. AbbVie Business Overview Table 118. AbbVie Liver Diseases Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. AbbVie Liver Diseases Therapeutics Drugs Product Portfolio Table 120. AbbVie Recent Development Table 121. Bayer Company Information Table 122. Bayer Business Overview Table 123. Bayer Liver Diseases Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Bayer Liver Diseases Therapeutics Drugs Product Portfolio Table 125. Bayer Recent Development Table 126. GlaxoSmithKline Company Information Table 127. GlaxoSmithKline Business Overview Table 128. GlaxoSmithKline Liver Diseases Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. GlaxoSmithKline Liver Diseases Therapeutics Drugs Product Portfolio Table 130. GlaxoSmithKline Recent Development Table 131. Merck Company Information Table 132. Merck Business Overview Table 133. Merck Liver Diseases Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Merck Liver Diseases Therapeutics Drugs Product Portfolio Table 135. Merck Recent Development Table 136. Johnson & Johnson Company Information Table 137. Johnson & Johnson Business Overview Table 138. Johnson & Johnson Liver Diseases Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Johnson & Johnson Liver Diseases Therapeutics Drugs Product Portfolio Table 140. Johnson & Johnson Recent Development Table 141. Shenzhen Kangtai Biological Products Company Information Table 142. Shenzhen Kangtai Biological Products Business Overview Table 143. Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Product Portfolio Table 145. Shenzhen Kangtai Biological Products Recent Development Table 146. North America Liver Diseases Therapeutics Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. North America Liver Diseases Therapeutics Drugs Sales by Country (2021-2026) & (K Units) Table 148. North America Liver Diseases Therapeutics Drugs Sales Market Share by Country (2021-2026) Table 149. North America Liver Diseases Therapeutics Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 150. North America Liver Diseases Therapeutics Drugs Sales Market Share Forecast by Country (2027-2032) Table 151. North America Liver Diseases Therapeutics Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. North America Liver Diseases Therapeutics Drugs Market Size by Country (2021-2026) & (US$ Million) Table 153. North America Liver Diseases Therapeutics Drugs Market Share by Country (2021-2026) Table 154. North America Liver Diseases Therapeutics Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. North America Liver Diseases Therapeutics Drugs Market Share Forecast by Country (2027-2032) Table 156. Europe Liver Diseases Therapeutics Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Europe Liver Diseases Therapeutics Drugs Sales by Country (2021-2026) & (K Units) Table 158. Europe Liver Diseases Therapeutics Drugs Sales Market Share by Country (2021-2026) Table 159. Europe Liver Diseases Therapeutics Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 160. Europe Liver Diseases Therapeutics Drugs Sales Market Share Forecast by Country (2027-2032) Table 161. Europe Liver Diseases Therapeutics Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Europe Liver Diseases Therapeutics Drugs Market Size by Country (2021-2026) & (US$ Million) Table 163. Europe Liver Diseases Therapeutics Drugs Market Share by Country (2021-2026) Table 164. Europe Liver Diseases Therapeutics Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Europe Liver Diseases Therapeutics Drugs Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Liver Diseases Therapeutics Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Liver Diseases Therapeutics Drugs Sales by Country (2021-2026) & (K Units) Table 168. Asia-Pacific Liver Diseases Therapeutics Drugs Sales Market Share by Country (2021-2026) Table 169. Asia-Pacific Liver Diseases Therapeutics Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 170. Asia-Pacific Liver Diseases Therapeutics Drugs Sales Market Share Forecast by Country (2027-2032) Table 171. Asia-Pacific Liver Diseases Therapeutics Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Asia-Pacific Liver Diseases Therapeutics Drugs Market Size by Country (2021-2026) & (US$ Million) Table 173. Asia-Pacific Liver Diseases Therapeutics Drugs Market Share by Country (2021-2026) Table 174. Asia-Pacific Liver Diseases Therapeutics Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Asia-Pacific Liver Diseases Therapeutics Drugs Market Share Forecast by Country (2027-2032) Table 176. Latin America Liver Diseases Therapeutics Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Latin America Liver Diseases Therapeutics Drugs Sales by Country (2021-2026) & (K Units) Table 178. Latin America Liver Diseases Therapeutics Drugs Sales Market Share by Country (2021-2026) Table 179. Latin America Liver Diseases Therapeutics Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 180. Latin America Liver Diseases Therapeutics Drugs Sales Market Share Forecast by Country (2027-2032) Table 181. Latin America Liver Diseases Therapeutics Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Latin America Liver Diseases Therapeutics Drugs Market Size by Country (2021-2026) & (US$ Million) Table 183. Latin America Liver Diseases Therapeutics Drugs Market Share by Country (2021-2026) Table 184. Latin America Liver Diseases Therapeutics Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Latin America Liver Diseases Therapeutics Drugs Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Liver Diseases Therapeutics Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Liver Diseases Therapeutics Drugs Sales by Country (2021-2026) & (K Units) Table 188. Middle East and Africa Liver Diseases Therapeutics Drugs Sales Market Share by Country (2021-2026) Table 189. Middle East and Africa Liver Diseases Therapeutics Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 190. Middle East and Africa Liver Diseases Therapeutics Drugs Sales Market Share Forecast by Country (2027-2032) Table 191. Middle East and Africa Liver Diseases Therapeutics Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Middle East and Africa Liver Diseases Therapeutics Drugs Market Size by Country (2021-2026) & (US$ Million) Table 193. Middle East and Africa Liver Diseases Therapeutics Drugs Market Share by Country (2021-2026) Table 194. Middle East and Africa Liver Diseases Therapeutics Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Middle East and Africa Liver Diseases Therapeutics Drugs Market Share Forecast by Country (2027-2032) Table 196. Key Raw Materials Table 197. Raw Materials Key Suppliers Table 198. Liver Diseases Therapeutics Drugs Distributors List Table 199. Liver Diseases Therapeutics Drugs Customers List Table 200. Research Programs/Design for This Report Table 201. Authors List of This Report Table 202. Secondary Sources Table 203. Primary Sources List of Figures Figure 1. Liver Diseases Therapeutics Drugs Image Figure 2. Global Liver Diseases Therapeutics Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Liver Diseases Therapeutics Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Liver Diseases Therapeutics Drugs Sales (2021-2032) & (K Units) Figure 5. Oral Liver Diseases Therapeutics Drugs Image Figure 6. Global Oral Liver Diseases Therapeutics Drugs Sales YoY Growth (2021-2032) & (K Units) Figure 7. Injection Liver Diseases Therapeutics Drugs Image Figure 8. Global Injection Liver Diseases Therapeutics Drugs Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Liver Diseases Therapeutics Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Liver Diseases Therapeutics Drugs Market Share by Type 2025 VS 2032 Figure 11. North America Liver Diseases Therapeutics Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America Liver Diseases Therapeutics Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe Liver Diseases Therapeutics Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Liver Diseases Therapeutics Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Liver Diseases Therapeutics Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Liver Diseases Therapeutics Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Liver Diseases Therapeutics Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Liver Diseases Therapeutics Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Liver Diseases Therapeutics Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Liver Diseases Therapeutics Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Liver Diseases Therapeutics Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospitals Image Figure 24. Global Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinics Image Figure 26. Global Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Liver Diseases Therapeutics Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Liver Diseases Therapeutics Drugs Market Share by Application 2025 VS 2032 Figure 31. North America Liver Diseases Therapeutics Drugs Sales Market Share in Volume by Application in 2025 Figure 32. North America Liver Diseases Therapeutics Drugs Sales Market Share in Value by Application in 2025 Figure 33. Europe Liver Diseases Therapeutics Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Europe Liver Diseases Therapeutics Drugs Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Liver Diseases Therapeutics Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Liver Diseases Therapeutics Drugs Sales Market Share in Value by Application in 2025 Figure 37. Latin America Liver Diseases Therapeutics Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Liver Diseases Therapeutics Drugs Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Liver Diseases Therapeutics Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Liver Diseases Therapeutics Drugs Sales Market Share in Value by Application in 2025 Figure 41. North America Liver Diseases Therapeutics Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Liver Diseases Therapeutics Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Liver Diseases Therapeutics Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Liver Diseases Therapeutics Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Liver Diseases Therapeutics Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Liver Diseases Therapeutics Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Liver Diseases Therapeutics Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Liver Diseases Therapeutics Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Liver Diseases Therapeutics Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Liver Diseases Therapeutics Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Liver Diseases Therapeutics Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Liver Diseases Therapeutics Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Liver Diseases Therapeutics Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Liver Diseases Therapeutics Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Liver Diseases Therapeutics Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Liver Diseases Therapeutics Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Liver Diseases Therapeutics Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Liver Diseases Therapeutics Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Liver Diseases Therapeutics Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Liver Diseases Therapeutics Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Liver Diseases Therapeutics Drugs Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Liver Diseases Therapeutics Drugs Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Liver Diseases Therapeutics Drugs
  • Injection Liver Diseases Therapeutics Drugs
Applications
  • Hospitals
  • Clinics
  • Other
Companies covered
  • Achillion Pharmaceuticals
  • Angion Biomedica
  • F. Hoffmann-La Roche
  • Gilead Sciences
  • LG Life Sciences
  • Phenex Pharmaceuticals
  • ProMetic Life Sciences
  • Raptor Pharmaceuticals
  • Verva Pharmaceuticals
  • AbbVie
  • Bayer
  • GlaxoSmithKline
  • Merck
  • Johnson & Johnson
  • Shenzhen Kangtai Biological Products

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Liver Diseases Therapeutics Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Liver Diseases Therapeutics Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Liver Diseases Therapeutics Drugs Market by Type
  6. 1.3.1 Oral Liver Diseases Therapeutics Drugs
  7. 1.3.2 Injection Liver Diseases Therapeutics Drugs
  8. 1.4 Global Liver Diseases Therapeutics Drugs Market Size by Type
  9. 1.4.1 Global Liver Diseases Therapeutics Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Liver Diseases Therapeutics Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Liver Diseases Therapeutics Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Liver Diseases Therapeutics Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Liver Diseases Therapeutics Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Liver Diseases Therapeutics Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Liver Diseases Therapeutics Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Liver Diseases Therapeutics Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Liver Diseases Therapeutics Drugs Industry Trends
  2. 2.2 Liver Diseases Therapeutics Drugs Industry Drivers
  3. 2.3 Liver Diseases Therapeutics Drugs Industry Opportunities and Challenges
  4. 2.4 Liver Diseases Therapeutics Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Liver Diseases Therapeutics Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Liver Diseases Therapeutics Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Liver Diseases Therapeutics Drugs Price (2021-2026)
  4. 3.4 Global Liver Diseases Therapeutics Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Liver Diseases Therapeutics Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Liver Diseases Therapeutics Drugs Company, Product Type & Application
  7. 3.7 Global Liver Diseases Therapeutics Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Liver Diseases Therapeutics Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Liver Diseases Therapeutics Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Liver Diseases Therapeutics Drugs Tier 1, Tier 2, and Tier 3
4 Liver Diseases Therapeutics Drugs Regional Status and Outlook
  1. 4.1 Global Liver Diseases Therapeutics Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Liver Diseases Therapeutics Drugs Historic Market Size by Region
  3. 4.2.1 Global Liver Diseases Therapeutics Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Liver Diseases Therapeutics Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Liver Diseases Therapeutics Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Liver Diseases Therapeutics Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Liver Diseases Therapeutics Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Liver Diseases Therapeutics Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Liver Diseases Therapeutics Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Liver Diseases Therapeutics Drugs by Application
  1. 5.1 Liver Diseases Therapeutics Drugs Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Other
  5. 5.2 Global Liver Diseases Therapeutics Drugs Market Size by Application
  6. 5.2.1 Global Liver Diseases Therapeutics Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Liver Diseases Therapeutics Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Liver Diseases Therapeutics Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Liver Diseases Therapeutics Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Liver Diseases Therapeutics Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Liver Diseases Therapeutics Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Liver Diseases Therapeutics Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Liver Diseases Therapeutics Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Achillion Pharmaceuticals
  2. 6.1.1 Achillion Pharmaceuticals Company Information
  3. 6.1.2 Achillion Pharmaceuticals Business Overview
  4. 6.1.3 Achillion Pharmaceuticals Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Achillion Pharmaceuticals Liver Diseases Therapeutics Drugs Product Portfolio
  6. 6.1.5 Achillion Pharmaceuticals Recent Developments
  7. 6.2 Angion Biomedica
  8. 6.2.1 Angion Biomedica Company Information
  9. 6.2.2 Angion Biomedica Business Overview
  10. 6.2.3 Angion Biomedica Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Angion Biomedica Liver Diseases Therapeutics Drugs Product Portfolio
  12. 6.2.5 Angion Biomedica Recent Developments
  13. 6.3 F. Hoffmann-La Roche
  14. 6.3.1 F. Hoffmann-La Roche Company Information
  15. 6.3.2 F. Hoffmann-La Roche Business Overview
  16. 6.3.3 F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Product Portfolio
  18. 6.3.5 F. Hoffmann-La Roche Recent Developments
  19. 6.4 Gilead Sciences
  20. 6.4.1 Gilead Sciences Company Information
  21. 6.4.2 Gilead Sciences Business Overview
  22. 6.4.3 Gilead Sciences Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Gilead Sciences Liver Diseases Therapeutics Drugs Product Portfolio
  24. 6.4.5 Gilead Sciences Recent Developments
  25. 6.5 LG Life Sciences
  26. 6.5.1 LG Life Sciences Company Information
  27. 6.5.2 LG Life Sciences Business Overview
  28. 6.5.3 LG Life Sciences Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 LG Life Sciences Liver Diseases Therapeutics Drugs Product Portfolio
  30. 6.5.5 LG Life Sciences Recent Developments
  31. 6.6 Phenex Pharmaceuticals
  32. 6.6.1 Phenex Pharmaceuticals Company Information
  33. 6.6.2 Phenex Pharmaceuticals Business Overview
  34. 6.6.3 Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Product Portfolio
  36. 6.6.5 Phenex Pharmaceuticals Recent Developments
  37. 6.7 ProMetic Life Sciences
  38. 6.7.1 ProMetic Life Sciences Company Information
  39. 6.7.2 ProMetic Life Sciences Business Overview
  40. 6.7.3 ProMetic Life Sciences Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 ProMetic Life Sciences Liver Diseases Therapeutics Drugs Product Portfolio
  42. 6.7.5 ProMetic Life Sciences Recent Developments
  43. 6.8 Raptor Pharmaceuticals
  44. 6.8.1 Raptor Pharmaceuticals Company Information
  45. 6.8.2 Raptor Pharmaceuticals Business Overview
  46. 6.8.3 Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Product Portfolio
  48. 6.8.5 Raptor Pharmaceuticals Recent Developments
  49. 6.9 Verva Pharmaceuticals
  50. 6.9.1 Verva Pharmaceuticals Company Information
  51. 6.9.2 Verva Pharmaceuticals Business Overview
  52. 6.9.3 Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Product Portfolio
  54. 6.9.5 Verva Pharmaceuticals Recent Developments
  55. 6.10 AbbVie
  56. 6.10.1 AbbVie Company Information
  57. 6.10.2 AbbVie Business Overview
  58. 6.10.3 AbbVie Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 AbbVie Liver Diseases Therapeutics Drugs Product Portfolio
  60. 6.10.5 AbbVie Recent Developments
  61. 6.11 Bayer
  62. 6.11.1 Bayer Company Information
  63. 6.11.2 Bayer Business Overview
  64. 6.11.3 Bayer Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Bayer Liver Diseases Therapeutics Drugs Product Portfolio
  66. 6.11.5 Bayer Recent Developments
  67. 6.12 GlaxoSmithKline
  68. 6.12.1 GlaxoSmithKline Company Information
  69. 6.12.2 GlaxoSmithKline Business Overview
  70. 6.12.3 GlaxoSmithKline Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 GlaxoSmithKline Liver Diseases Therapeutics Drugs Product Portfolio
  72. 6.12.5 GlaxoSmithKline Recent Developments
  73. 6.13 Merck
  74. 6.13.1 Merck Company Information
  75. 6.13.2 Merck Business Overview
  76. 6.13.3 Merck Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Merck Liver Diseases Therapeutics Drugs Product Portfolio
  78. 6.13.5 Merck Recent Developments
  79. 6.14 Johnson & Johnson
  80. 6.14.1 Johnson & Johnson Company Information
  81. 6.14.2 Johnson & Johnson Business Overview
  82. 6.14.3 Johnson & Johnson Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Johnson & Johnson Liver Diseases Therapeutics Drugs Product Portfolio
  84. 6.14.5 Johnson & Johnson Recent Developments
  85. 6.15 Shenzhen Kangtai Biological Products
  86. 6.15.1 Shenzhen Kangtai Biological Products Company Information
  87. 6.15.2 Shenzhen Kangtai Biological Products Business Overview
  88. 6.15.3 Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Product Portfolio
  90. 6.15.5 Shenzhen Kangtai Biological Products Recent Developments
7 North America by Country
  1. 7.1 North America Liver Diseases Therapeutics Drugs Sales by Country
  2. 7.1.1 North America Liver Diseases Therapeutics Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Liver Diseases Therapeutics Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Liver Diseases Therapeutics Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Liver Diseases Therapeutics Drugs Market Size by Country
  6. 7.2.1 North America Liver Diseases Therapeutics Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Liver Diseases Therapeutics Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Liver Diseases Therapeutics Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Liver Diseases Therapeutics Drugs Sales by Country
  2. 8.1.1 Europe Liver Diseases Therapeutics Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Liver Diseases Therapeutics Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Liver Diseases Therapeutics Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Liver Diseases Therapeutics Drugs Market Size by Country
  6. 8.2.1 Europe Liver Diseases Therapeutics Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Liver Diseases Therapeutics Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Liver Diseases Therapeutics Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Liver Diseases Therapeutics Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Liver Diseases Therapeutics Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Liver Diseases Therapeutics Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Liver Diseases Therapeutics Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Liver Diseases Therapeutics Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Liver Diseases Therapeutics Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Liver Diseases Therapeutics Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Liver Diseases Therapeutics Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Liver Diseases Therapeutics Drugs Sales by Country
  2. 10.1.1 South America Liver Diseases Therapeutics Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Liver Diseases Therapeutics Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Liver Diseases Therapeutics Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Liver Diseases Therapeutics Drugs Market Size by Country
  6. 10.2.1 South America Liver Diseases Therapeutics Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Liver Diseases Therapeutics Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Liver Diseases Therapeutics Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Liver Diseases Therapeutics Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Liver Diseases Therapeutics Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Liver Diseases Therapeutics Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Liver Diseases Therapeutics Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Liver Diseases Therapeutics Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Liver Diseases Therapeutics Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Liver Diseases Therapeutics Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Liver Diseases Therapeutics Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Liver Diseases Therapeutics Drugs Value Chain Analysis
  2. 12.1.1 Liver Diseases Therapeutics Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Liver Diseases Therapeutics Drugs Production Mode & Process
  7. 12.2 Liver Diseases Therapeutics Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Liver Diseases Therapeutics Drugs Distributors
  10. 12.2.3 Liver Diseases Therapeutics Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst